Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty

ClinicalTrials.gov ID: NCT00931515

Public ClinicalTrials.gov record NCT00931515. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 8:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multi-center, Randomized, Controlled Clinical Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The NuBac device is indicated for reconstruction following nucleotomy in skeletally mature patients at least 18 years of age with symptomatic single level degenerative disc disease (DDD) at L4/L5 only. DDD is defined as discogenic back pain with or without leg pain; with degeneration of the disc as confirmed by patient history, physical examination, radiographic studies showing: decreased disc height, contained herniated nucleus, vacuum phenomenon (dark disc) OR positive discography at the affected level. These DDD patients should have no more than Grade 1 spondylolisthesis at the involved level and should have failed at least six months of conservative, non-operative care. Demonstrate non-inferiority compared to ProDisc.

Study identification

NCT ID
NCT00931515
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Enrollment
30 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2009 (Type not available)
Primary completion
Dec 2012 (Actual)
Completion
Dec 2012 (Actual)
Last update posted
May 26, 2014

2009 – 2012

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
16
Facility City State ZIP Site status
Spine Group Beverly Hills Beverly Hills California 90211 —
Tower Orthopedics & Sports Medicine Beverly Hills California 90211 —
Bergey Spine Institute Colton California 92324 —
Loma Linda University - Faculty Physicians Loma Linda California 92354 —
University of Colorado, Anschutz Outpatient Pavilion Aurora Colorado 80045 —
The Spine Institute Loveland Colorado 80538 —
Florida Orthopaedic Institute Tampa Florida 33637 —
Bone & Joint Physicians Oak Lawn Illinois 60453 —
Heartland Hand & Spine Orthopedic Center Merriam Kansas 66204 —
Orthopaedic Surgical Associates Marquette Michigan 49855 —
The Orthopedic Center of St. Louis St Louis Missouri 63017 —
Buffalo Neurosurgery Buffalo New York 14224 —
Southern New York NeuroSurgical Group Johnson City New York 13790 —
Carolina Neurosurgery and Spine Associates Charlotte North Carolina 28204 —
NeuroSpine Institute Eugene Oregon 97401 —
Neurospine Solutions, PC Bristol Tennessee 37620 —
Milwaukee Spinal Specialists Milwaukee Wisconsin 53211 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00931515, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 26, 2014 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00931515 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →